In the bond market, yields edged higher following the latest readings on the U.S. economy. Growth for the overall economy ...

U.S. stock indexes are wavering following a strong profit report from Google’s parent company, while drops for Eli Lilly and ...

Q3 sales in weight loss drugs Mounjaro and Zepbound were more than 20% lower than consensus analyst forecasts, spooking investors.

It’s just another earnings week in the life of pharmaceutical CEOs, with blockbuster expectations running up against cruel ...

Fly over the electrifying scenes of India’s Holi Festival with this mesmerizing drone footage. Watch as crowds gather to ...

Reliable Used Ford Off-Roaders You Can Buy For Less Than $15,000 ...

Over the last month, Dell and Super Micro have been sparring in the headlines with new product releases. Just two weeks ago, ...

NEW YORK — U.S. stock indexes edged lower Wednesday after drops for Eli Lilly and chip companies overshadowed a jump for ...

The S&P 500 slipped 0.3 percent after drifting between small gains and losses several times, though it's still near its ...

Eli Lilly ( LLY) is planning to advertise its blockbuster weight loss drug, Zepbound, for the first time next month. Despite investor and industry recognition of the branded GLP-1 drug, "unaided ...